Mozobil is a medication that is primarily used in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells from the bone marrow to the bloodstream for autologous transplantation in patients with non-Hodgkin’s lymphoma or multiple myeloma. Here is what you need to know about Mozobil, Its uses, benefits, side effects, and warnings.
Uses of Mozobil
Mozobil mobilizes hematopoietic stem cells in the bone marrow into the bloodstream for peripheral blood stem-cell transplantation. This process may be used in the treatment of:
- Non-Hodgkin’s lymphoma
- Multiple myeloma
Mozobil works by blocking a molecule known as CXCR4, which keeps the stem cells in the bone marrow. By blocking CXCR4, Mozobil helps the stem cells to move into the bloodstream, where they can be collected for transplantation.
Benefits of Mozobil
There are several benefits to using Mozobil in stem-cell transplantation, including:
- Increased yield of stem cells: Mozobil has been shown to increase the number of stem cells collected during transplantation.
- Reduced time to engraftment: Mozobil has been shown to reduce the time it takes for the transplanted stem cells to engraft and start producing new blood cells.
- Improved overall survival: Studies have shown that using Mozobil in stem-cell transplantation can lead to improved overall survival rates in patients with multiple myeloma and non-Hodgkin’s lymphoma.
Side Effects of Mozobil
Like all medications, Mozobil can cause side effects. The most common side effects of Mozobil are:
- Injection site reactions: pain, swelling, redness, or itching at the injection site.
- Gastrointestinal side effects: nausea, vomiting, diarrhea, or constipation.
- Headache: mild to moderate headaches have been reported in some patients.
In rare cases, Mozobil can cause more serious side effects such as allergic reactions, anemia, and leukocytosis. If you experience any severe side effects while taking Mozobil, you should seek medical attention immediately.
Warnings for Mozobil
Before taking Mozobil, you should be aware of the following warnings:
- Mozobil should only be used in combination with granulocyte-colony stimulating factor (G-CSF) and under the supervision of a healthcare professional.
- Mozobil should not be used if you are allergic to plerixafor or any of the other ingredients in Mozobil.
- Mozobil may interact with other medications, so it is important to tell your healthcare provider about all the medications you are taking.
- If you are pregnant or breastfeeding, you should talk to your healthcare provider before taking Mozobil.
FAQs
Mozobil is administered through a subcutaneous injection.
Mozobil works quickly, usually within 30 minutes of administration.
Mozobil is typically given once a day for up to four days before stem-cell collection.
Mozobil is only FDA-approved for use in combination with G-CSF in patients with multiple myeloma and non-Hodgkin’s lymphoma.
Mozobil may be covered by insurance, but coverage varies. You should check with your insurance provider to see if Mozobil is covered under your plan.
